Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Moringa oleifera flower hexane extract (MOF-H) is a botanical extract derived from the flowers of the *Moringa oleifera* tree, commonly known as the drumstick tree. The extract is typically produced using ultrasound-assisted extraction (UAE) with hexane as a non-polar solvent to isolate specific lipophilic phytochemicals. Research into MOF-H focuses on its potential therapeutic properties, including antioxidant, antimicrobial, and anticancer activities. In vitro studies have demonstrated that the extract possesses cytotoxic effects against breast cancer (MCF-7) and ovarian cancer (ES-2) cell lines. Additionally, it has shown antifungal activity and the ability to scavenge free radicals, although it is generally found to be less potent in these regards compared to more polar extracts like ethyl acetate or methanol.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on moringa oleifera flower hexane extract.